Sensitive and real-time method for evaluating corneal barrier considering tear flow.

We developed a new electrophysiological method mimicking tear flow to evaluate the epithelial tight junction of rabbit cornea quantitatively. We investigated the effect of tear flow on the corneal damage induced by ophthalmic preservatives using this method. An Ussing chamber system with Ag/AgCl electrodes was used in the electrophysiological experiment. The excised rabbit cornea was mounted in the Ussing chamber and the precorneal solution in the chamber was perfused with a peristaltic pump at the rate of human tear flow. Corneal transepithelial electrical resistance (TEER) was monitored as corneal barrier ability. In the electrophysiological method mimicking tear flow, we observed stable TEER, which rapidly decreased with benzalkonium chloride (BAC), an eye drop preservative. Using this system, we first found that 0.004% BAC decreased corneal TEER reversibly. A high concentration of BAC showed strong irreversible damage to the tight junction. The influence of BAC on corneal TEER was not only concentration-dependent but also tear flow rate-dependent. The electrophysiological method mimicking tear flow was useful to evaluate the corneal barrier quantitatively. Using this method, we clarified that the tear flow was important to protect the corneal damage induced by preservatives.

[1]  P. Artursson,et al.  Mechanisms of absorption enhancement and tight junction regulation , 1994 .

[2]  Hitoshi Sasaki,et al.  Acute Corneal Epithelial Change after Instillation of Benzalkonium Chloride Evaluated Using a Newly Developed in vivo Corneal Transepithelial Electric Resistance Measurement Method , 2007, Ophthalmic Research.

[3]  H. Sasaki,et al.  Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients. , 2007, Biological & pharmaceutical bulletin.

[4]  J. Piontek,et al.  Structure and function of claudins. , 2008, Biochimica et biophysica acta.

[5]  S. Klyce Relationship of epithelial membrane potentials to corneal potential. , 1973, Experimental eye research.

[6]  Alessio Fasano,et al.  Tight junction modulation and its relationship to drug delivery. , 2006, Advanced drug delivery reviews.

[7]  J. Robinson,et al.  Lacrimal and instilled fluid dynamics in rabbit eyes. , 1973, Journal of pharmaceutical sciences.

[8]  S. Klyce,et al.  Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. , 1977, Investigative ophthalmology & visual science.

[9]  C. Baudouin Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma , 2008, Acta ophthalmologica.

[10]  P. Gastaud,et al.  Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. , 1998, Current eye research.

[11]  Liying Wang,et al.  The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit , 1992, Pharmaceutical Research.

[12]  J. Nordmann,et al.  Vision related quality of life and topical glaucoma treatment side effects , 2003, Health and quality of life outcomes.

[13]  C. Baudouin,et al.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication , 2002, The British journal of ophthalmology.

[14]  L. González-Mariscal,et al.  Crosstalk of tight junction components with signaling pathways. , 2008, Biochimica et biophysica acta.

[15]  P. Edman Biopharmaceutics of Ocular Drug Delivery , 1992 .

[16]  C. Baudouin,et al.  New tools for the evaluation of toxic ocular surface changes in the rat. , 2007, Investigative ophthalmology & visual science.

[17]  H. Sasaki,et al.  Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.

[18]  N. Burstein Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. , 1980, Investigative ophthalmology & visual science.

[19]  R. Noecker,et al.  Corneal and Conjunctival Changes Caused by Commonly Used Glaucoma Medications , 2004, Cornea.

[20]  R. Schoenwald,et al.  Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors , 1983 .

[21]  J. Robinson,et al.  Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.